FDA Approves LUVOX(R) CR Extended-Release Capsules For The Treatment Of Social Anxiety Disorder (SAD) And Obsessive Compulsive Disorder (OCD)

Monday, March 3rd, 2008

Solvay Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved LUVOX® CR (fluvoxamine maleate) Extended-Release Capsules for the treatment of social anxiety disorder (SAD) and obsessive compulsive disorder (OCD) in adults. In January 2007, Solvay Pharmaceuticals licensed the right to market LUVOX CR (fluvoxamine maleate) Extended-Release Capsules ...

Protein Shines Light On Cancer Response

Monday, February 25th, 2008

A technique that specifically "tags" tumors responding to chemotherapy may offer a new strategy for determining a cancer treatment's effectiveness within days of starting treatment, according to a new study by Vanderbilt-Ingram Cancer Center investigators. Appearing online ahead of print in Nature Medicine, the researchers report the identification of a small ...

Family Context Affects Genetic And Environmental Hormonal Response To Stress In Children

Thursday, February 21st, 2008

A study conducted on 346 19-month-old twins by an international team led by Universite Laval professor of psychology Michel Boivin reveals that the genetic and environmental bases of hormonal response to stress depend on the context in which a child grows up. This is the first time such an effect ...

Recent Studies Suggest Popular ‘Diet Pill’ Reduces Acne Breakouts

Monday, February 18th, 2008

As crazy as it sounds, recent studies conducted at Stanford and Wake Forest Schools of Medicine suggest there's a connection between stubborn stress-related belly bulge, unsightly acne flare-ups and the so-called "Belly Fat" pill, Relacore(R)... and that link is stress. By now we've all heard that stress increases cortisol (the ...